Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06293235

Towards Optimal Fertility, Fathering and Fatherhood studY

This case-control study involving fertile and subfertile couples aims to identify male factors related to pregnancy likelihood, create a fertility index measure combining male and female factors to predict pregnancy likelihood, and examine how male factors relate to the semen physical and biological characteristics.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year–49 year

Sex eligibility

All sexes

Study type

Observational

Primary location

KK Women's and Children's Hospital

Singapore, 229899

Location status: Recruiting

Location contact

Benjarat Oh

CONTACT

[email protected]

+6583684641

About this study

Paternal contributions to fertility and reproductive health outcomes have been understudied, despite promising evidence from animal studies. This study aims to investigate the male contribution to pregnancy likelihood and explore the underlying biological mechanisms. Specifically, the investigators aim to (1) identify male factors associated with pregnancy rate; (2) develop a fertility index combining modifiable factors for both males and females to predict pregnancy rate; and (3) explore the relationship of male modifiable factors with semen physical and molecular characteristics. This is a case-control study with 480 fertile and subfertile males (along with their female partners), recruited from KK Women's and Children's Hospital. The investigators will use questionnaires to collect data on socio-demographic characteristics, clinical, lifestyle, and environmental factors; analyze metabolic and stress biomarkers from blood samples; and measure semen parameters including sperm motility, density, morphology, volume, DNA fragmentation, DNA methylation, gene expression, and seminal plasma oxidative status. Findings from this proposed study will pave the way for developing lifestyle-based or medical interventions to enhance male and couple reproductive health, and potentially benefiting future offspring health.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subfertile couples:

  • men aged ≥21-49 years
  • men with a female partner aged 21-39 years
  • couples who are not able to conceive for at least 12 months
  • couples who are Singapore citizen or permanent resident

Fertile couples:

  • men aged 21-49 years
  • men with a female partner aged 21-39 years
  • men with proven fertility defined as those female partners who are currently pregnant and with viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study
  • couples with attempted time to conceive within 12 months to achieve this pregnancy or with unplanned pregnancy
  • couples who are Singapore citizen or permanent resident

Exclusion criteria

Subfertile couples:

  • male infertility of a known aetiology including azoospermia, retrograde ejaculation, genetic disorders, cancer treatment, or testes trauma
  • female infertility diagnosis as confirmed by diagnostic imaging or having severe endometriosis
  • female partners with irregular menstrual cycle >35 days
  • couples with known chromosomal abnormalities

Fertile couples:

  • couples who achieve pregnancy after oocyte or spermatozoa donation
  • couples with known chromosomal abnormalities
  • female partners with known uterine abnormalities

Treatment and study plan

Lifestyle and metabolic indicators

Other

Socio-demographics, health history, behavioural characteristics, environmental exposures, anthropometric measurements, body fat composition, metabolic and stress biomarkers, semen physical and molecular characteristics.

Other names: Semen quality and characteristics

Primary outcomes

  1. Pregnancy rate

    Time frame: Up to 16 weeks of gestation

    Defined by viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study

Secondary outcomes

  1. Fertility index

    Time frame: Through study completion, an average of 3 years

    Defined by a composite index score derived from both male and female predictive factors

  2. Oxidative stress

    Time frame: Through study completion, an average of 3 years

    Defined by oxidative status measured from blood and semen samples using the micro-NMR

  3. Semen volume

    Time frame: Up to 2 years

    Assessed by semen analysis in ml

  4. Sperm concentration

    Time frame: Up to 2 years

    Assessed by semen analysis in million/ml

  5. Sperm total motility

    Time frame: Up to 2 years

    Assessed by semen analysis in percent

  6. Sperm progressive motility

    Time frame: Up to 2 years

    Assessed by semen analysis in percent

  7. Total progressive motile sperm count

    Time frame: Up to 2 years

    measured by multiplying the semen volume (ml) by sperm concentration (million/ml) and the percentage of progressively motile sperm

  8. Single strand sperm DNA fragmentation

    Time frame: Up to 2 years

    Measured by the AI-powered semen analyzer

  9. Double strand sperm DNA fragmentation

    Time frame: Up to 2 years

    Measured by the AI-powered semen analyzer

  10. mRNA level

    Time frame: Through study completion, an average of 3 years

    From blood and semen samples through transcriptomics analysis

  11. sncRNA level

    Time frame: Through study completion, an average of 3 years

    From blood and semen samples through transcriptomics analysis

  12. DNA methylation

    Time frame: Through study completion, an average of 3 years

    From blood and semen samples through bisulfite sequencing

Other outcomes

  1. Sperm morphology

    Time frame: Up to 2 years

    Assessed by semen analysis

Study contacts

Contact information is provided by the study sponsor or research team.

Benjarat Oh

CONTACT

[email protected]

63948105 ext. 65

Sponsors and collaborators

Lead sponsor

KK Women's and Children's Hospital

Other Gov

Registry information

Official study title

Investigating Male Factors and Their Relationships With Reproductive Health Outcomes in Singapore: Towards Optimal Fertility, Fathering and Fatherhood studY

Acronym: TOFFFY

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Mar 5, 2024
Registry last updated
Mar 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.